BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22804809)

  • 1. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of poor response to oral propranolol in infantile hemangiomas.
    Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
    Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
    Xiao Q; Li Q; Zhang B; Yu W
    Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
    Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
    J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.
    Ji Y; Chen S; Wang Q; Xiang B; Xu Z; Zhong L; Yang K; Lu G; Qiu L
    Sci Rep; 2018 Mar; 8(1):4264. PubMed ID: 29523832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Results of Oral Propranolol Treatment Protocol for Periocular Infantile Hemangioma: Should There Be Any Contraindication?
    Ghahvehchian H; Kashkouli MB; Ghanbari S; Karimi N; Abdolalizadeh P; Abri Aghdam K
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):61-69. PubMed ID: 38241619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional betamethasone versus oral propranolol for localized infantile hemangiomas of the lip.
    Chang SJ; Chang L; Chang HF; Shang Y; Qiu Y; Lin X
    J Plast Reconstr Aesthet Surg; 2023 Dec; 87():54-60. PubMed ID: 37804648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessively High Chronic Propranolol Overdose in Infantile Hemangioma: A Case Report.
    Alshammari H; Alessa A; Elsharawy Y; Alghanem A; Alhammad AM
    Am J Case Rep; 2023 Nov; 24():e941765. PubMed ID: 38008932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When to stop propranolol for infantile hemangioma.
    Chang L; Gu Y; Yu Z; Ying H; Qiu Y; Ma G; Chen H; Jin Y; Lin X
    Sci Rep; 2017 Feb; 7():43292. PubMed ID: 28225076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
    Maliqari N; Duka E; Kuneshka L
    Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile Hemangiomas of the Head and Neck: A Single-Center Experience.
    Kizmazoglu D; Ince D; Olgun Y; Cecen E; Guleryuz H; Erdag T; Olgun N
    Children (Basel); 2024 Mar; 11(3):. PubMed ID: 38539346
    [No Abstract]   [Full Text] [Related]  

  • 12. Propranolol Monotherapy in Multifocal/Diffuse Infantile Hepatic Hemangiomas in Indian Children: A Case Series.
    Ray G; Das K; Sarkar A; Bose D; Halder P
    J Clin Exp Hepatol; 2023; 13(4):707-712. PubMed ID: 37440944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our experience with propranolol for infantile hemangioma.
    Wu Y; Zhao P; Song W; Lu W; Dai T; Wang L
    Skin Res Technol; 2023 Apr; 29(4):e13310. PubMed ID: 37113082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development.
    Giese RA; Turner M; Cleves M; Gardner JR; Richter GT
    Int J Pediatr; 2021; 2021():6669383. PubMed ID: 33927773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas.
    Praticò AD; Caraci F; Pavone P; Falsaperla R; Drago F; Ruggieri M
    Drug Saf Case Rep; 2015 Dec; 2(1):6. PubMed ID: 27747719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9.
    Wu S; Wang B; Chen L; Xiong S; Zhuang F; Huang X; Wang M; Huang Z
    Exp Ther Med; 2015 Sep; 10(3):1079-1083. PubMed ID: 26622443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.
    Liu X; Qu X; Zheng J; Zhang L
    PLoS One; 2015; 10(9):e0138100. PubMed ID: 26375455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of complex infantile haemangioma in a resource-poor setting.
    Natawidjaja R; Wang E
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25053694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis.
    Kum JJ; Khan ZA
    Pediatr Res; 2014 Mar; 75(3):381-8. PubMed ID: 24296797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review.
    Xu SQ; Jia RB; Zhang W; Zhu H; Ge SF; Fan XQ
    World J Pediatr; 2013 Aug; 9(3):221-9. PubMed ID: 23929254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.